CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Successful triple therapy of patients with chronic hepatitis C genotype 1 infection leads to significant improvement of non-invasive liver fibrosis tests
DOI 10.1055/s-0033-1360913
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Höner zu Siederdissen, B Maasoumy, K Deterding, K Port, J Kirschner, J Cornberg, MP Manns, H Wedemeyer, M Cornberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and Aim: The new standard of care for patients with chronic hepatitis C genotype 1 (GT1) is triple therapy with pegylated interferon alpha (P), ribavirin (R) and a HCV protease inhibitor (PI). Sustained virological response (SVR) has been shown to lower the incidence of HCC, improve survival and even regression of liver cirrhosis is suggested in some cases. However, data are limited, especially for triple…
Zitieren
Zitierempfehlung
C Höner zu Siederdissen, B Maasoumy, K Deterding, K Port, J Kirschner, J Cornberg, MP Manns, H Wedemeyer, M Cornberg (2014) Successful triple therapy of patients with chronic hepatitis C genotype 1 infection leads to significant improvement of non-invasive liver fibrosis tests. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0033-1360913
Mit CareLit weiterarbeiten